Skip to main content
OpenTrials

Clinical trial condition

Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

Explore clinical trials studying Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia trial results

Completed

A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

NCT05597085

Conditions
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • Fortis Memorial Research Institute Gurugram, Haryana, India
  • Malabar Cancer Center Thalassery, Kerala, India
  • Rajiv Gandhi Cancer Institute and Research Centre New Delhi, National Capital Territory of Delhi, India
  • Indo-American Cancer & Research Centre Hyderabad, Telangana, India
View Trial Details

Related conditions